The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma

Journal of Endocrinological Investigation

Volumn 34, Issue 8 SUPPL., 2011, Pages

  Castagna, M G ^a   Tala Jury, H P ^a   Cipri, C ^a   Belardini, V ^a   Fioravanti, C ^a   Pasqui, L ^a   Sestini, F ^a   Theodoropoulou, A ^a   Pacini, Furio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Neck ultrasound; rhTSH; Thyroglobulin; Thyroid cancer; Ultrasensitive Tg assays

Indexed keywords

RECOMBINANT HORMONE; THYROGLOBULIN; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIATED THYROID CANCER; ECHOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN DETERMINATION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL ASSAY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; YOUNG ADULT;

EID: 84855477381     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7571     Document Type: Article

References (18)

1. Pacini F, Pinchera A, Giani C, Grasso L, Doveri F, Baschieri L. Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J Endocrinol Invest 1980, 3: 283-92. (Pubitemid 11218502)
2. Pacini F, Lippi F. Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement. J Endocrinol Invest 1999, 22: 25-9.
3. Pacini F, Elisei R, Fugazzola L, et al. Post-surgical follow-up of differentiated thyroid cancer. J Endocrinol Invest 1995, 18: 165-6.
4. Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003, 88: 3668-73. (Pubitemid 37034512)
5. Torlontano M, Crocetti U, Augello G, et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 1311 whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 2006, 91: 60-3. (Pubitemid 43069118)
6. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003, 97: 90-6. (Pubitemid 36033867)
7. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19: 1167-214.
8. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006, 154: 787-803. (Pubitemid 43997716)
9. lervasi A, lervasi G, Ferdeghini M, et al. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf) 2007, 67: 434-41.
10. Smallridge RC, Meek SE, Morgan MA, et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007, 92: 82-7. (Pubitemid 46075007)
11. Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 <1 ng/ml determined by traditional assays? Clin Endocrinol (Oxf) 2008, 68: 338-42. (Pubitemid 351257849)
12. Spencer C, Fatemi S, Singer P, Nicoloff J, Lopresti J. Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. Thyroid 2010, 20: 587-95.
13. Schlumberger M, Hitzel A, Toubert ME, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007, 92: 2487-95. (Pubitemid 47037347)
14. th ed. New York: Springer-Verlag, 2002.
15. Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999, 84: 3877-85. (Pubitemid 30644169)
16. nd Part: Physicochemical characterization and certification. Ann Biol Clin 1996, 54: 343-8.
17. Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med 1982, 2: 685-99. (Pubitemid 13074757)
18. Giovanella L, Maffioli M, Ceriani L, De Palma D, Spriano G. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma. Clin Chem Lab Med 2009, 47: 1001-4.